08/19/2026
The decisions that derail commercialization rarely look like mistakes at first.
More often, they look like reasonable assumptions.
About the problem.
The market.
What investors need to hear.
What early interest really means.
What evidence matters.
What will drive adoption.
Next week, MESH Founder Bill Schick, eMBA, FCMO and Katherine King French, MBA, Director of Strategy at Smith+Nephew, are teaming up for an MDG Boston Lunch & Learn Masterclass:
Why Great Science Still Fails
A practical look at seven costly mistakes that can surface before a raise, pilot or launch—and how to catch them earlier.
Bill + Kate bring complementary perspectives across:
• Startup growth
• Investment
• Commercialization
• Market strategy
• Global MedTech leadership
The session will combine research, market data and real-world company examples with a practical founder workbook to help attendees pressure-test their own plans.
The goal:
• Spot the risks.
• Challenge the assumptions.
• Leave with a focused 30-day action plan.
When: August 26th, 12–1 PM ET
Location: Online
Tickets: $10
Registration link in the comments.